Open Access

Current status and future prospects of drug eluting stents for restenosis / Sadašnjost i budućnost stentova za restenozu koji otpuštaju lijekove


1. E. Sousa, P. Serruys and M. Costa, New frontiers in cardiology: drug-eluting stents: Part I, Circulation 107 (2003) 2274-2279; DOI: 10.1161/01.CIR.0000069330.41022.90.10.1161/01.CIR.0000069330.41022.90Search in Google Scholar

2. E. Edelman and C. Rogers, Pathobiologic responses to stenting, Am. J. Cardiol. 81 (1998) 4E-6E; DOI: 10.1016/S0002-9149(98)00189-1.10.1016/S0002-9149(98)00189-1Search in Google Scholar

3. P. Serruys, B. Strauss and H. Van Beusekom, Stenting of coronary arteries: has a modern Pandora’s Box been opened? J. Am. Coll Cardiol. 17 (1991) 143B-154B; DOI: 10.1016/0735-1097(91)90951-5.10.1016/0735-1097(91)90951-5Search in Google Scholar

4. M. Costa, D. Foley and P. Serruys, Restenosis: the Problem and How to Deal With It, in Practical Interventional Cardiology (Eds. E. Grech and D. Ramsdale), 2nd ed., Martin Dumitz, London 2002, pp. 279-294.Search in Google Scholar

5. D. Whelan, H. Van Beusekom and W. Van der Giessen, Mechanisms of drug loading and release kinetics, Semin. Interv. Cardiol. 3 (1998) 127-131.Search in Google Scholar

6. W. Van der Giessen, A. Lincoff and R. Schwartz, Marked inflammatory sequelae to implantation of biodegradable and non-biodegradable polymers in porcine coronary arteries, Circulation 94 (1996) 1690-1697; DOI: 10.1161/01.CIR.94.7.1690.10.1161/01.CIR.94.7.1690Search in Google Scholar

7. D. Drachman, E. Edelman and P. Seifert, Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months, J. Am. Coll. Cardiol. 36 (2000) 2325-2332; DOI: 10.1016/S0735-1097(00)01020-2.10.1016/S0735-1097(00)01020-2Search in Google Scholar

8. B. Ratner, The blood compatibility catastrophe, J. Biomed. Mater. Res. 27 (1993) 283-287; DOI: 10.5897/AJPP11.107.10.5897/AJPP11.107Search in Google Scholar

9. M. Lovich, C. Creel and K. Hong, Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel, J. Pharm. Sci. 90 (2001) 1324-1335; DOI: 10.1002/JPS.1085.10.1002/jps.1085Search in Google Scholar

10. R. Braun-Dullaeus, M. Mann and V. Dzau, Cell cycle progression: new therapeutic target for vascular proliferative disease, Circulation 98 (1998) 82-89; DOI: 10.1161/01.CIR. in Google Scholar

11. C. Morton Allison, D. Crossman and J. Gunn, The influence of physical stent parameters upon restenosis, Pathol. Biol. 52 (2004) 196-205; DOI: 10.1016/J.PATBIO.2004. in Google Scholar

12. C. Rogers, Optimal stent design for drug delivery, Rev. Cardiovasc. Med. 5 (2004) S9-S15.Search in Google Scholar

13. K. Lau, A. Johan, U. Sigwart and J. Hung, A stent is not just a stent: stent construction and design do matter in its clinical performance, Singapore Med. J. 45 (2004) 305-312.Search in Google Scholar

14. A. Colombo, G. Stankovic and J. W. Moses, Selection of coronary stents, J. Am. Coll. Cardiol. 40 (2002) 1021-1033.10.1016/S0735-1097(02)02123-XSearch in Google Scholar

15. D. Stoeckel, C. Bonsignore and S. Duda, A survey of stent designs, Minim. Invasive Ther. Allied Technol. 11 (2002) 137-147.10.1080/136457002760273340Search in Google Scholar

16. L. Lim, Biocompatability of stent materials, MIT Undergrad. Res. J. 11 (2004) 33-37.Search in Google Scholar

17. J. Bier, P. Zalesky and S. Li, A new bioabsorbable intravascular stent: in vitro assessment of hemodynamic and morphometric characteristics, J. Interven. Cardiol. 5 (1992) 187-194.Search in Google Scholar

18. B. Berk, J. Gordon and R. Alexander, Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty, J. Am. Coll. Cardiol. 17 (1991) 111B-117B; DOI: 10.1016/0735-1097(91)90946-7.10.1016/0735-1097(91)90946-7Search in Google Scholar

19. C. Pepine, J. Hirshfeld and R. Macdonald, A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty, M-HEART Group Circ. 81 (1990) 1753-1761; DOI: 10.1161/01.CIR.81.6.1753.10.1161/01.CIR.81.6.1753Search in Google Scholar

20. I. De Scheerder, K. Wang and K. Wilczek, Local methylprednisolone inhibition of foreign body response to coated intracoronary stents, Coron. Artery. Dis. 7 (1996) 161-166.10.1097/00019501-199602000-00011Search in Google Scholar

21. A. M. Lincoff, J. G. Furst and S. G. Ellis, Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model, J. Am. Coll. Cardiol. 29 (1997) 808-816; DOI: 10.1016/S0735-1097(96)00584-0.10.1016/S0735-1097(96)00584-0Search in Google Scholar

22. D. Holmes, M. Savage and J. LaBlanche, Results of prevention of restenosis with tranilast and its outcomes (PRESTO) trial, Circulation 106 (2002) 1243-1250. DOI: 10.1161/01.CIR.0000028335.31300DA.Search in Google Scholar

23. A. Farb, M. John, E. Acampado, F. D. Kolodgie, M. F. Prescott and R. Virmani, Oral everolimus inhibits in-stent neointimal growth, Circulation 106 (2002) 2379-2384; DOI: 10.1161/01.CIR.0000033973.06059.04.10.1161/01.CIR.0000033973.06059.04Search in Google Scholar

24. P. B. Schiff and S. B. Horwitz, Taxol stabilizes microtubules in mouse fibroblast cells, Proc. Natl. Acad. Sci. USA 77 (1980) 1561-1565.10.1073/pnas.77.3.1561Search in Google Scholar

25. P. W. Serruys, Long-term effects of angiopeptin treatment in coronary angioplasty: reduction of clinical events but not angiographic restenosis, Circulation 92 (1995) 2759-2760.Search in Google Scholar

26. R. K. Aggarwal, D. C. Ireland, M. A. Azrin, M. D. Ezekowitz, D. P. de Bono and A. H. Gershlick, Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody, Circulation 94 (1996) 3311-3317; DOI: 10.1161/01.CIR.94.12.3311.10.1161/01.CIR.94.12.3311Search in Google Scholar

27. C. Li, W. J. Cantor, N. Nili, R. Robinson, L. Fenkell and Y. L. Tran, Arterial repair after stenting and the effects of GM6001, a matrix metalloproteinase inhibitor, J. Am. Coll. Cardiol. 39 (2002) 1852-1858; DOI: 10.1016/S0735-1097(02)01873-9.10.1016/S0735-1097(02)01873-9Search in Google Scholar

28. C. Rogers, S. Parikh, P. Seifert and E. R. Edelman, Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair, Circulation 94 (1996) 2909-2914; DOI: 10.1161/01.CIR.94.11.2909.10.1161/01.CIR.94.11.29098941120Search in Google Scholar

29. J. Aoki, P. W. Serruys, H. van Beusekom, A. T. Ong, E. P. McFadden and G. Sianos, Endothelial progenitor cell capture by stents coated with antibody against CD34: The healing-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry, J. Am. Coll. Cardiol. 45 (2005) 1574-1579.Search in Google Scholar

30. D. J. Cohen, Economics of coronary restenosis: implications of drug-eluting stents,; last access: April 22, 2012Search in Google Scholar

31. P. W. Serruys, P. de Jaegere, F. Kiemeneij, C. Macaya, W. Rutsch, G. Heyndrickx, H. Emanuelsson, J. Marco, V. Legrand, P. Materne, J. Belardi, U. Sigwart, A. Colombo, J. J. Gay, P. Henvel, J. Delcan and M. Morel, A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease, New Engl. J. Med. 331 (1994) 489-495; DOI: 10.10.1056/NEJM199408253310801.10.1056/NEJM199408253310801Search in Google Scholar

32. H. Tamai, K. Igaki, E. Kyo, K. Kosuga, A. Kawashima, S. Matsui, H. Komori, T. Tsuji, S. Motohara and H. Uehata, Initial and 6-month results of biodegradable poly-L-lactic acid coronary stents in humans, Circulation 102 (2000) 399-404; DOI: 10.1161/01.CIR.102.4.399.10.1161/01.CIR.102.4.399Search in Google Scholar

33. J. A. Ormiston, P. W. Serruys, E. Regar, D. Dudek, L. Thuesen, M. W. Webster, Y. Onuma, H. M. Garcia-Garcia, R. McGreevy and S. Veldhof, A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial, Lancet 371 (2008) 899-907; DOI: 10.1016/S0140-6736(08)60415-8.10.1016/S0140-6736(08)60415-8Search in Google Scholar

34. J. A. Ormiston and P. W. Serruys, Bioabsorbable coronary stents, Circ. Cardiovasc. Interv. 2 (2009) 255-260; DOI: 10.1161/CIRCINTERVENTIONS.109.859173.10.1161/CIRCINTERVENTIONS.109.859173Search in Google Scholar

35. S. Ramcharitar and P. W. Serruys, Fully biodegradable coronary stents: progress to date, Am. J. Cardiovasc. Drugs 8 (2008) 305-314.10.2165/00129784-200808050-00003Search in Google Scholar

36. R. Erbel, C. Di Mario, J. Bartunek, J. Bonnier, B. de Bruyne, F. R. Eberli, P. Erne, M. Haude, B. Heublein, M. Horrigan, C. Ilsley, D. Bose, J. Koolen, T. F. Luscher, N. Weissman and R. Waksman, Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial, Lancet 369 (2007) 1869-1875; DOI: 10.1016/S0140-6736(07)60853-8.10.1016/S0140-6736(07)60853-8Search in Google Scholar

37. N. Tada, R. Virmani, G. Grant, L. Bartlett, A. Black, C. Clavijo, U. Christians, R. Betts, D. Savage, S. H. Su, J. Shulze and S. Kar, Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model, Circ. Cardiovasc. Interv. 3 (2010) 174-183; DOI: 10.1161/CIRCINTERVENTIONS.109.87522.Search in Google Scholar

38. J. R. Costa, Jr., A. Abizaid, R. Costa, F. Feres, L. F. Tanajura, G. Maldonado, R. Staico, D. Siqueira, A. G. Sousa, R. Bonan and J. E. Sousa, 1-Year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial, JACC Cardiovasc. Interv. 2 (2009) 422-427; DOI: 10.1016/j.jcin.2009. in Google Scholar

39. J. Aoki, P. W. Serruys, H. van Beusekom, A. T. L. Ong, E. P. McFadden and G. Sianos, Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) registry, J. Am. Coll. Cardiol. 45 (2005) 1574-1579; DOI: 10.1016/j.jacc.2005. in Google Scholar

40. H. J. Duckers, S. Silber, R. D. Winter, P. D. Heijer, B. Rensing and M. Rau, Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent, EuroIntervention 3 (2007) 67-75.Search in Google Scholar

41. M. Co, E. Tay, C. H. Lee, K. K Poh, A. Low and J. Lim, Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: Intermediate- to long-term clinical follow-up, Am. Heart. J. 155 (2008) 128-132; DOI: 10.1016/j.ahj.2007. in Google Scholar

42. A. Abizaid and J. R. Costa, Jr., New drug-eluting stents: An overview on biodegradable and polymer-free next-generation stent system, Circ. Cardiovasc. Interv. 3 (2010) 384-393; DOI: 10.1161/CIRCINTERVENTIONS.109.891192.10.1161/CIRCINTERVENTIONS.109.89119220716758Search in Google Scholar

43. C. Lovadahl, J. Thyber and A. Hultgardh-Nilsson, The synthetic metalloproteinase inhibitor batimastat suppresses injury induced phosphorylation of MAP kinase ERK/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro, J. Vasc. Res. 37 (2000) 345-354; DOI: 10.1159/000025750.10.1159/00002575011025397Search in Google Scholar

44. P. W. Serruys, S. Garg, A. Abizaid, J. Ormiston, S. Windecker, S. Verheye, C. Dubois, J. Stewart, K. E. Hauptmann, J. Schofer, K. Stangl, B. Witzenbichler, M. Wiemer, E. Barbato, T. de Vries, A. M. den Drijver, H. Otake, L. Meredith, S. Toyloy and P. Fitzgerald, A randomised comparison of novolimus-eluting and zotarolimus eluting coronary stents: 9-month follow-up results of the EXCELLA II study, EuroIntervention 6 (2010) 195-205.Search in Google Scholar

Publication timeframe:
4 times per year
Journal Subjects:
Pharmacy, other